IBDEI0YA ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16695,2)
 ;;=^303272
 ;;^UTILITY(U,$J,358.3,16696,0)
 ;;=344.04^^84^1003^10
 ;;^UTILITY(U,$J,358.3,16696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16696,1,3,0)
 ;;=3^344.04
 ;;^UTILITY(U,$J,358.3,16696,1,4,0)
 ;;=4^Quadriplegia C5-C7,Incomplete
 ;;^UTILITY(U,$J,358.3,16696,2)
 ;;=^303273
 ;;^UTILITY(U,$J,358.3,16697,0)
 ;;=344.09^^84^1003^11
 ;;^UTILITY(U,$J,358.3,16697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16697,1,3,0)
 ;;=3^344.09
 ;;^UTILITY(U,$J,358.3,16697,1,4,0)
 ;;=4^Quadriplegia NEC
 ;;^UTILITY(U,$J,358.3,16697,2)
 ;;=^303274
 ;;^UTILITY(U,$J,358.3,16698,0)
 ;;=344.1^^84^1003^6
 ;;^UTILITY(U,$J,358.3,16698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16698,1,3,0)
 ;;=3^344.1
 ;;^UTILITY(U,$J,358.3,16698,1,4,0)
 ;;=4^Paraplegia NOS
 ;;^UTILITY(U,$J,358.3,16698,2)
 ;;=^90028
 ;;^UTILITY(U,$J,358.3,16699,0)
 ;;=344.2^^84^1003^1
 ;;^UTILITY(U,$J,358.3,16699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16699,1,3,0)
 ;;=3^344.2
 ;;^UTILITY(U,$J,358.3,16699,1,4,0)
 ;;=4^Diplegia Upper Limbs
 ;;^UTILITY(U,$J,358.3,16699,2)
 ;;=^268452
 ;;^UTILITY(U,$J,358.3,16700,0)
 ;;=344.31^^84^1003^2
 ;;^UTILITY(U,$J,358.3,16700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16700,1,3,0)
 ;;=3^344.31
 ;;^UTILITY(U,$J,358.3,16700,1,4,0)
 ;;=4^Monoplegia Lower Limb Dom Side
 ;;^UTILITY(U,$J,358.3,16700,2)
 ;;=^303276
 ;;^UTILITY(U,$J,358.3,16701,0)
 ;;=344.32^^84^1003^3
 ;;^UTILITY(U,$J,358.3,16701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16701,1,3,0)
 ;;=3^344.32
 ;;^UTILITY(U,$J,358.3,16701,1,4,0)
 ;;=4^Monoplegia Lower Limb NonDom Side
 ;;^UTILITY(U,$J,358.3,16701,2)
 ;;=^303277
 ;;^UTILITY(U,$J,358.3,16702,0)
 ;;=344.41^^84^1003^4
 ;;^UTILITY(U,$J,358.3,16702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16702,1,3,0)
 ;;=3^344.41
 ;;^UTILITY(U,$J,358.3,16702,1,4,0)
 ;;=4^Monoplegia Upper Limb Dom Side
 ;;^UTILITY(U,$J,358.3,16702,2)
 ;;=^303279
 ;;^UTILITY(U,$J,358.3,16703,0)
 ;;=344.42^^84^1003^5
 ;;^UTILITY(U,$J,358.3,16703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16703,1,3,0)
 ;;=3^344.42
 ;;^UTILITY(U,$J,358.3,16703,1,4,0)
 ;;=4^Monoplegia Upper Limb NonDom Side
 ;;^UTILITY(U,$J,358.3,16703,2)
 ;;=^303280
 ;;^UTILITY(U,$J,358.3,16704,0)
 ;;=90732^^85^1004^6
 ;;^UTILITY(U,$J,358.3,16704,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16704,1,1,0)
 ;;=1^90732
 ;;^UTILITY(U,$J,358.3,16704,1,3,0)
 ;;=3^PNEUMOVAX
 ;;^UTILITY(U,$J,358.3,16705,0)
 ;;=86580^^85^1004^7
 ;;^UTILITY(U,$J,358.3,16705,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16705,1,1,0)
 ;;=1^86580
 ;;^UTILITY(U,$J,358.3,16705,1,3,0)
 ;;=3^PPD WITH CONTROLS
 ;;^UTILITY(U,$J,358.3,16706,0)
 ;;=90658^^85^1004^3^^^^1
 ;;^UTILITY(U,$J,358.3,16706,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16706,1,1,0)
 ;;=1^90658
 ;;^UTILITY(U,$J,358.3,16706,1,3,0)
 ;;=3^FLU VACCINE IM (FLULAVAL)
 ;;^UTILITY(U,$J,358.3,16707,0)
 ;;=90471^^85^1004^1^^^^1
 ;;^UTILITY(U,$J,358.3,16707,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16707,1,1,0)
 ;;=1^90471
 ;;^UTILITY(U,$J,358.3,16707,1,3,0)
 ;;=3^IMMUNIZATION ADMIN, SINGLE
 ;;^UTILITY(U,$J,358.3,16708,0)
 ;;=90472^^85^1004^2^^^^1
 ;;^UTILITY(U,$J,358.3,16708,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16708,1,1,0)
 ;;=1^90472
 ;;^UTILITY(U,$J,358.3,16708,1,3,0)
 ;;=3^IMMUNIZATION ADMIN, 2+
 ;;^UTILITY(U,$J,358.3,16709,0)
 ;;=86486^^85^1004^8^^^^1
 ;;^UTILITY(U,$J,358.3,16709,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16709,1,1,0)
 ;;=1^86486
 ;;^UTILITY(U,$J,358.3,16709,1,3,0)
 ;;=3^SKIN TEST, NOS ANTIGEN
 ;;^UTILITY(U,$J,358.3,16710,0)
 ;;=90656^^85^1004^4^^^^1
 ;;^UTILITY(U,$J,358.3,16710,1,0)
 ;;=^358.31IA^3^2
 ;;
 ;;$END ROU IBDEI0YA
